No such message found

...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: News from a Chinese/Japenese Article about Zenith

Very interesting LongRVXer. A Zenith Phase 2 discussion is kind of surprising since we've heard nothing out of Phase 1 yet. But never hurts to plan ahead, assuming that the Phase 2 text wasn't an artifact of google! Also, the date of that article 10/25/16 indicates that these are recent discussions/developments. Hmmmmmm.

BearDownAZ

Share
New Message
Please login to post a reply